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Influenza A virus is an important human pathogen
causing significant morbidity and mortality every
year and threatening the human population with
epidemics and pandemics. Therefore, it is important
tounderstand the biology of this virus todevelop strat-
egies to control its pathogenicity. Here, we demon-
strate that influenza A virus inhibits macroautophagy,
a cellular process known to be manipulated by diverse
pathogens. Influenza A virus infection causes accu-
mulation of autophagosomes by blocking their fusion
with lysosomes, andone viral protein,matrix protein 2,
is necessary and sufficient for this inhibition of auto-
phagosome degradation. Macroautophagy inhibition
by matrix protein 2 compromises survival of influenza
virus-infected cells but does not influence viral repli-
cation. We propose that influenza A virus, which also
encodes proapoptotic proteins, is able to determine
the death of its host cell by inducing apoptosis and
also by blocking macroautophagy.
INTRODUCTION
Influenza virus is a segmented negative-sense RNA virus. The
eight RNA segments of influenza A viruses encode 11 proteins
(Palese and Shaw, 2007). The three largest segments are dedi-
cated to produce each of the three RNA polymerase compo-
nents, and one of them encodes an additional polypeptide, poly-
merase basic protein 1-frame 2 (PB1-F2), which promotes cell
death (Chen et al., 2001). Two of the segments encode the
surface glycoproteins hemagglutinin (HA) and neuraminidase
(NA), involved in sialic acid adhesion and fusion in endosomes.
One segment encodes the nucleoprotein (NP) involved in viralCell HoRNA packaging and transport and one the two matrix proteins
(M1 and M2). M2 possesses proton channel activity that allows
virion acidification for efficient uncoating after fusion in endo-
somes. On top of these mostly structural proteins encoding
RNA segments, the smallest segment encodes the nonstructural
proteins NS1 and NS2. NS2 or NEP supports the nuclear export of
viral RNA packaged with NP. NS1 compromises the interferon
(IFN) response to viral infectionby multiple mechanisms, including
binding to double-stranded RNAs and preventing their recogni-
tion by the innate immune system. Although many aspects of
influenza virus pathogenesis have been investigated, a more
detailed understanding of the virus-host interaction, especially
infection-induced changes in the biology of the host cell, could
reveal critical points of the influenza virus life cycle that could be
targeted to cripple virus replication and diminish virus production.
This is especially important because the virus causes significant
morbidity and mortality even outside pandemics. Influenza virus
infection is associated with 20,000 deaths in the US in a typical
year and causes, in addition, significant losses in the tens of
billions of US dollars to the economy due to debilitating infections
(Yewdell and Garcı´a-Sastre, 2002). Even more dramatically, the
virus causes periodic pandemics with a higher death toll. There-
fore, it is important to characterize additional control mechanisms
and the virus’ countermeasures against them.
One such control mechanism could be macroautophagy, and
indeed, many pathogens have been found to interfere with this
catabolic process (Schmid and Mu¨nz, 2007). Autophagic and
proteasomal degradation are the two main catabolic processes
for proteins in eukaryotic cells. While the proteasome discards
primarily short-lived soluble ubiquitinated proteins (Ciechanover,
2005), autophagy is thought to degrade cellular organelles and
protein aggregates of primarily long-lived proteins (Mizushima
and Klionsky, 2007). Autophagy consists of at least three path-
ways: microautophagy, macroautophagy, and chaperone-medi-
ated autophagy. Of those, macroautophagy is best character-
ized and has been implicated in both innate and adaptivest & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc. 367
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isolation membrane forms around its substrate to generate an
autophagic vesicle surrounded by two membranes. This auto-
phagosome then fuses with late endosomes and lysosomes to
degrade the inner autophagosome membrane and the autopha-
gic cargo. More than 30 essential autophagy genes (atg) have
been identified in yeast for this process (Mizushima and Klion-
sky, 2007). While the function of most of these is still unknown,
two ubiquitin-like systems have been characterized as essential
for autophagosome generation (Ohsumi, 2001). In one of them,
Atg12 is coupled to Atg5, which then, in complex with Atg16L1,
decorates the outer membrane of the isolation membrane. Upon
autophagosome completion, this complex is recycled. The
Atg12/Atg5/Atg16L1 complex is essential for autophagosome
formation and might influence the curvature of the forming auto-
phagosome as well as guide coupling of Atg8/LC3, the second
ubiquitin-like molecule involved in macroautophagy (Hanada
et al., 2007; Fujita et al., 2008). This second ubiquitin-like system
couples Atg8/LC3 to phosphatidylethanolamine at the outer and
inner autophagosomal membrane. Atg8/LC3 stays with the
completed autophagosome and is in part degraded with the
inner vesicle membrane by lysosomal hydrolysis. These ubiqui-
tin-like conjugation reactions are initiated by class III phosphati-
dylinositol 3-kinase (PI3K) complexes, which include the Atg6/
Beclin-1 protein. Interestingly, Atg6/Beclin-1-positive com-
plexes that contain Atg14L seem to support autophagosome
formation, while others that contain UVRAG may facilitate the
fusion between autophagosomes and lysosomes (Matsunaga
et al., 2009; Zhong et al., 2009; Itakura et al., 2008).
This knowledge of the molecular mechanisms of autophago-
some generation allowed us to analyze macroautophagy regula-
tion by influenza virus infection. We found that influenza A virus
infection arrests autophagosome degradation in large perinu-
clear structures. We could identify influenza A M2 as sufficient
and required for this phenotype, compromising macroautoph-
agy, which is required for the survival of the infected host cells.
Therefore, we propose that influenza A virus has at least two
mechanisms to regulate cell death of its host cell: PB1-F2
inducing apoptosis and M2 inhibiting antiapoptotic macro-
autophagy.
RESULTS
Autophagosomes Accumulate after Influenza Virus
Infection
In order to investigate whether the cellular macroautophagy level
is altered in response to influenza A virus infection, we infected
stably GFP-LC3-transfected human epithelial cell lines with influ-
enza virus strain A/Aichi/68 (H3N2). Cells were infected at a low
multiplicity of infection (moi between 0.6 and 0.8), which typically
resulted in an infection rate of 50%–70% (data not shown). At
these mois, cell viability was maintained at 90% 24 hr postinfec-
tion, whereas 48 hr postinfection, up to 50% of apoptotic cells
could be detected (data not shown). We therefore chose to
analyze cells 24 hr postinfection. In comparison to uninfected
cells, influenza-infected cells showed a strong increase in
GFP-LC3+ autophagosomes (Figure 1A). Autophagosome accu-
mulation was observed in A549 human lung epithelial cells,368 Cell Host & Microbe 6, 367–380, October 22, 2009 ª2009 ElsevMLE-12 mouse lung epithelial cells, MDAMC human breast
carcinoma cells, and HaCat human keratinocyte cells (Figure 1A).
The increase in autophagosomes in A549 human lung epithelial
cells occurred after infection with different strains of influenza
virus (A/Aichi/68 [H3N2], A/WSN/33 [H1N1], and A/PR8/34
[H1N1]) (Figure 1B). The increased autophagosome number
could also be observed by western blot at the level of endoge-
nous lipidated Atg8/LC3 (Figure 1C). When lysates of uninfected
and infected cells were analyzed by anti-Atg8/LC3 immunoblot,
the lipidated and therefore faster-migrating Atg8/LC3-II form
was strongly increased in influenza-infected epithelial cell lines
(Figure 1C). In addition to Atg8/LC3 as an autophagosome
marker, we also analyzed accumulation of previously described
autophagosome cargo (Klionsky et al., 2008). Both polyubiquiti-
nated protein aggregates and p62/sequestosome 1 (SQSTM1),
previously described macroautophagy substrates (Komatsu
et al., 2006; Hara et al., 2006; Bjørkøy et al., 2005; Pankiv
et al., 2007), accumulated in autophagosomes upon influenza
infection (Figures 1D and 1E). These data demonstrate that
autophagosomes accumulate after epithelial infection with influ-
enza A virus, suggesting that macroautophagy is a process that
is regulated during influenza virus infection.
Live Influenza Virus Infection Is Required
for Autophagosome Accumulation
To investigate how long after infection the autophagosome
increase occurs, we prepared lysates at various time points
postinfection and analyzed them by anti-Atg8/LC3 western
blot. Atg8/LC3-II was first detectably increased 10 hr after infec-
tion of lung epithelial cells and gradually accumulated to higher
levels at later time points (Figure S1A). Thus, the autophagosome
accumulation was not a rapid response to influenza virus infec-
tion, suggesting that viral or cellular factors might have to be
produced first.
To see whether cells have to be productively infected or
whether uptake of inactivated viral particles and perhaps recog-
nition of pathogen-associated molecular patterns (PAMPs)
within these is sufficient to mediate autophagosome accumula-
tion, we exposed cells to live or heat-inactivated influenza A
virus and analyzed their lipidated Atg8/LC3-II levels by western
blot analysis (Figure S1B) and autophagosome content by
GFP-Atg8/LC3 fluorescence microscopy (Figure S1C). Only
live influenza virus was able to elicit an increase of autophago-
somes as indicated by GFP-Atg8/LC3-II, endogenous Atg8/
LC3-II, and GFP-Atg8/LC3 vesicle accumulation, whereas
heat-inactivated virus did not cause any change in Atg8/LC3-II
levels or GFP-Atg8/LC3 distribution (Figures S1B and S1C).
Thus, contact with the components or endocytosis of inactivated
virus particles is not sufficient to elicit autophagosome accumu-
lation.
To visualize more directly that productive infection is neces-
sary for macroautophagy regulation, we stained uninfected and
infected cells with M1-specific antibodies to see if the autopha-
gosome accumulation would only occur in cells that produce viral
protein. Indeed, autophagosome accumulation and formation
of large perinuclear autophagosomes were only detectable in
cells that expressed influenza A M1, whereas M1-negative cells
did not show these changes in intracellular GFP-Atg8/LC3 dis-
tribution (Figure S1D). This indicates that autophagosomeier Inc.
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Macroautophagy Inhibition by InfluenzaFigure 1. Classical Autophagosome Accumulation after Influenza A Virus Infection
(A) Stably GFP-Atg8/LC3-transfected epithelial cell lines A549, MLE-12, MDAMC, and HaCat were infected with influenza A/Aichi/68 virus and analyzed for GFP-
Atg8/LC3-positive autophagosome accumulation 24 hr later by fluorescence microscopy. DAPI was used to stain nuclear DNA. Scale bar: 30 mm.
(B) GFP-Atg8/LC3-transfected A549 human lung epithelial cells were infected with different influenza A virus strains (A/Aichi/68, A/WSN/33, and A/PR8/34) and
analyzed after 24 hr. One of three experiments is shown. Scale bar: 30 mm.
(C) The human epithelial cell lines HaCat and 293T were infected with influenza A/Aichi/68 virus at an moi of 0.1. Twenty-four hours postinfection, lysates of unin-
fected and infected cells were analyzed by western blot analysis for Atg8/LC3. Unconjugated (LC3-I) and lipidated Atg8/LC3 (LC3-II) can be distinguished by their
apparent molecular weights of 18 kDa and 16 kDa, respectively. * marks an unspecific band, detected by our Atg8/LC3 antiserum. One of three experiments is
shown.
(D and E) Twenty-four hours after influenza A virus infection, colocalization of GFP-ATG8/LC3 and the classical macroautophagy substrates polyubiquitinated
proteins (D) and p62/SQSTM1 (E) were analyzed by immune fluorescence microscopy. Nuclear DNA was stained with DAPI. Scale bar: 20 mm. One of three exper-
iments is shown.accumulation occurs only in directly and productively infected
cells and is not mediated by a soluble factor secreted in response
to influenza virus infection. In line with these observations, we
could rule out that type I IFNs were responsible for the observed
effect, because blocking of the IFNa/b receptor did not abrogate
the influenza-mediated autophagosome accumulation (data not
shown). Therefore, productive influenza A infection causes auto-
phagosome accumulation.Cell HoInfluenza Virus Infection Blocks Autophagosome
Degradation
Since autophagosomes are transient vesicles that deliver their
cargo within minutes for lysosomal hydrolysis, their accumula-
tion could result from increased formation or decreased degra-
dation (Klionsky et al., 2008). To investigate which of these two
mechanisms was responsible for autophagosome accumulation
upon influenza virus infection and if fusion of autophagosomest & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc. 369
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compartments with red fluorescent LysoTracker and performed
live cell imaging (Figure 2A). In uninfected cells, about 25% of
GFP-Atg8/LC3+ vesicles overlapped with LysoTracker staining,
indicating that a fraction of autophagosomes had fused with
lysosomes and had become acidified. In contrast, in influenza-
infected cells, almost no overlap between autophagosomes
and LysoTracker staining was observed; especially the large
perinuclear autophagosomes were devoid of LysoTracker stain-
ing (Figure 2A). This suggests that, after influenza virus infection,
autophagosomes do not fuse with acidic compartments; even
so, acidified lysosomes were present at similar numbers in
infected cells. In order to rule out that autophagosomes
fuse with lysosomes but are not efficiently acidified in infected
cells, we investigated GFP-Atg8/LC3 colocalization with the
Figure 2. Autophagosomes Do Not Fuse with Acidified
Proteolytic Lysosomes in Influenza-Infected Cells
(A) Live cell imaging was performed to analyze colocalization of
LysoTracker-stained acidified vesicles and GFP-Atg8/LC3-posi-
tive autophagosomes in uninfected and influenza A virus-infected
cells. Scale bar: 15 mm. Representative still images of two inde-
pendent experiments are shown.
(B) Furthermore, fusion of autophagosomes with lysosomes was
analyzed as colocalization of the autophagosome marker GFP-
Atg8/LC3 with the lysosome marker LAMP1. Nuclear DNA was
stained with DAPI and infected cells with M1-specific antibodies.
Scale bar: 30 mm. One of three experiments is shown.
(C) GFP-Atg8/LC3-transfected A549 human lung epithelial and
MDAMC human breast carcinoma cells were infected with influ-
enza A virus at an moi of 0.4 for 24 hr. Then the indicated samples
were treated for 6 hr with the lysosomal inhibitor chloroquine (CQ),
and lipidated endogenous Atg8/LC3-II and lipidated transfected
GFP-Atg8/LC3-II content was analyzed by Atg8/LC3-specific
western blot analysis. One of three experiments is shown.
(D) The tandem reporter construct mRFP-GFP-Atg8/LC3 was
transiently transfected into uninfected or influenza A virus-infected
A549 human lung epithelial cells. GFP (sensitive to acidification
and lysosomal degradation) and RFP (insensitive to acidification
and lysosomal degradation) fluorescence of the reporter construct
were analyzed by fluorescence microscopy. DAPI was used to
stain nuclear DNA. Scale bar: 20 mm. One of three experiments
is shown.
lysosome-associated membrane protein 1 (LAMP1)
(Figure 2B). While GFP-Atg8/LC3 partially overlapped
with LAMP1 in uninfected lung epithelial cells, this
autophagosome marker did not colocalize with
LAMP1 in influenza virus-infected cells. Especially,
the large GFP-Atg8/LC3-positive perinuclear vesicles
were LAMP1-negative. These data suggested that
autophagosomes do not efficiently fuse with lyso-
somes in influenza-infected cells.
In order to confirm this block of autophagosome
fusion with lysosomes in influenza virus-infected cells,
we analyzed the turnover of autophagosomes. For this
purpose, influenza virus-infected and mock-infected
cells were treated, 24 hr postinfection, with the lyso-
somal proteolysis inhibitor chloroquine (CQ) for 6 hr.
In uninfected cells, lipidated Atg8/LC3-II and GFP-
Atg8/LC3-II accumulated upon CQ treatment, indi-
cating that autophagosomes are turned over by lyso-
somal proteolysis (Figure 2C). In contrast, in influenza-infected
cells, no further accumulation of Atg8/LC3-II and GFP-Atg8/
LC3-II could be observed in response to CQ treatment, demon-
strating that autophagosomes were not turned over at a signifi-
cant rate by lysosomal proteolysis in infected cells. As a second
indication that lysosomal turnover of autophagosomes is defec-
tive in influenza virus-infected cells, we made use of a tandem
reporter construct, mRFP-GFP-Atg8/LC3 (Kimura et al., 2007).
The GFP moiety of this tandem autophagosome marker is sensi-
tive to lysosomal proteolysis and quenching in acidic pH, while
the mRFP is not. Therefore, the green fluorescent component
of the composite yellow fluorescence for this mRFP-GFP-LC3
reporter is lost upon autophagosome fusion with lysosomes.
This fluorescence change from yellow to red can be used to
visualize lysosomal proteolysis and localization in acidified370 Cell Host & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc.
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lung epithelial cells, few yellow autophagosomes but a high
number of mRFP-positive autolysosomes could be detected
after transient transfection of mRFP-GFP-Atg8/LC3 (Figure 2D).
In contrast, influenza virus infection led to the accumulation of
mRFP and GFP double-positive vesicles, especially in the peri-
nuclear region, suggesting impaired autophagosome fusion
with lysosomes. These data suggest that influenza virus infection
inhibits fusion of autophagosomes with acidified LAMP1+ lyso-
somes and thereby prevents degradation of macroautophagy
substrates.
Influenza Virus-Infected Cells Accumulate Small
Autophagosomeswith HighMobility and Immobile Large
Perinuclear Autophagosomes
In order to investigate if the block of autophagosome fusion with
lysosomes in influenza virus-infected cells could result from
impaired autophagosome mobility, we observed GFP-Atg8/
LC3-transfected A549 lung epithelial cells by live cell imaging.
Most influenza-infected cells contained numerous small auto-
phagosomes in addition to one large GFP-LC3+ perinuclear
vesicle ofR5 mm diameter, whereas uninfected cells contained
a smaller number of evenly distributed, small-to-medium size
autophagosomes (Figure 3A). The larger autophagosomes
(R1 mm) in both uninfected and infected cells moved only slowly;
the very large perinuclear autophagosome, which accumulated
upon influenza virus infection, appeared almost immobile when
followed over a period of 10 min (Figure 3A). In uninfected cells,
smaller autophagosomes (<1 mm) moved slightly more rapidly
than large autophagosomes and therefore could be seen to
move slowly when their tracks were recorded over a period of
30 s (average speed = 0.1 mm/s) (Figure 3B, left). Strikingly, small
autophagosomes in influenza-infected cells moved rapidly
throughout the cytosol (Figure 3B and Movie S1). The movement
seemed to be random and nondirectional, since vesicles moved
toward and away from the central perinuclear region containing
immobile large autophagosomes. The average speed of auto-
phagosomes in infected cells was about 0.3 mm/s and therefore
significantly elevated compared to autophagosomes in unin-
fected cells. These findings suggest that the block in autophago-
some fusion with lysosomes is not due to impaired autophago-
some mobility.
In addition to this kinetic description of the autophagosome
populations in influenza virus-infected cells, we analyzed the
ultrastructural features of the large perinuclear GFP-Atg8/LC3+
vesicles. We analyzed influenza virus-infected human lung
epithelial cells by electron microscopy in order to distinguish if
these large GFP-Atg8/LC3-positive structures are autophago-
somes of very large size or clusters of small autophagosomes.
This also allowed us to look at the autophagosome content/
composition at the ultrastructural level. In uninfected cells,
a few small (0.5–1 mm) autophagosomes or autolysosomes con-
taining internal lipid vesicles and electron-dense material could
be observed (Figure 3C, top row, black arrows). In contrast,
24 hr after influenza infection, most cells contained extremely
large autophagosomes (up to 7 mm) that sometimes even
reached the size of the nucleus (Figure 3C, bottom row, black
arrows). The giant autophagosomes contained electron-dense,
amorphous material and did not seem to contain large amountsCell Hosof other organelles, such as mitochondria or rough ER, which we
could readily identify in the cytoplasm (Figure 3C). Our ultrastruc-
tural analysis of influenza-infected cells confirms that autopha-
gosome numbers are strongly increased after influenza infection.
Furthermore, it suggests that at least some of the large GFP-
LC3-positive structures observed in fluorescence microscopy
represent one unusually large autophagosome that might origi-
nate from the fusion of smaller autophagosomes.
M2 Protein of Influenza A Virus Is Sufficient to Block
Autophagosome Degradation
In order to investigate how influenza A virus causes this dramatic
change in autophagic activity of infected cells, we transiently
transfected GFP-Atg8/LC3-positive A549 cells with expression
plasmids encoding for the influenza A virus proteins PB2, NP,
NS1, M1, M2, and HA. Twenty-four hours after transfection, we
observed that only M2-transfected cells showed a strong accu-
mulation of GFP-Atg8/LC3 vesicles by immunofluorescence
microscopy analysis (Figure 4A), while the introduction of the
other influenza A virus proteins did not result in autophagosome
accumulation. The increased autophagosome number upon M2
expression could also be observed by western blot analysis as
an accumulation of lipidated Atg8/LC3-II (Figure 4B). In order
to compare transfection levels of influenza A proteins, we used
FLAG-tagged constructs (Figure 4B). Although the FLAG tag
can interfere with protein function, it did not cause autophago-
some accumulation when coupled to NP and allowed autopha-
gosome stabilization by M2. M2-mediated autophagosome
accumulation was also observed in different human and mouse
cell types, 293T human kidney epithelial cells, MDAMC human
breast carcinoma cells, mouse embryonic fibroblasts (MEFs),
and human melanoma cell lines (data not shown). In order to
confirm that M2 expression also recapitulated the block of auto-
phagosome fusion with lysosomes as observed during live influ-
enza virus infection, we investigated autophagosome acidifica-
tion and GFP degradation/quenching of the mRFP-GFP-Atg8/
LC3 reporter construct in M2-transfected cells. Indeed, no
overlay between autophagosomes and LysoTracker staining
was observed in M2-transfected A549 cells (data not shown).
Moreover, coexpression of M2 and mRFP-GFP-LC3 tandem
construct led to the accumulation of mRFP and GFP double-
positive vesicles, especially in the perinuclear region, suggesting
impaired autophagosome fusion with lysosomes (data not
shown). This observation was not the consequence of a general
defect in the fusion with lysosomes, because we observed that
fusion of fluorescent Sepharose beads containing phagosomes
with lysosomes was intact in influenza A virus-infected and in
M2-transfected cells (data not shown). These data indicate
that M2 transfection recapitulates the macroautophagy block
observed after influenza A virus infection.
During our immune fluorescence microscopy analysis, we
noted that M2 staining localized to the cell membrane and to
perinuclear autophagosomes (Figure 4A). We therefore per-
formed a detailed colocalization analysis of GFP-LC3 and M2
in infected A549 cells (Figure 4C). We found a significant partial
colocalization of these two proteins with a Pearson coefficient
of 0.7, as depicted in the scatter plot (Figure 4C, lower panel)
showing the pixel distribution of the two corresponding chan-
nels (number of colocalized voxels: 63,619). This example ist & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc. 371
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Macroautophagy Inhibition by InfluenzaFigure 3. Mobility and Ultrastructure of Autophagosomes in Influenza A Virus-Infected Cells
(A) Live cell imaging of GFP-Atg8/LC3-transfected A549 human lung epithelial cells was performed to analyze autophagosome mobility. Still images of uninfected
and influenza A virus-infected cells taken at the indicated time points of live cell imaging document the immobility of the accumulated large perinuclear autopha-
gosomes.
(B) Autophagosome tracking in uninfected and influenza A-infected cells. Left: vesicle tracks are displayed as color-coded tracks, indicating the distance traveled
by one vesicle during the indicated observation period (t = 0 in blue, t = endpoint in white). Right: average speed of autophagosomes was determined in three
independent fields and summarized. One of three experiments is shown. Error bars indicate SD.
(C) Electron micrographs of uninfected and influenza A virus-infected A549 human lung epithelial cells. Small autophagic structures (black arrows, upper row)
were detected in uninfected cells, whereas large autophagic structures (black arrows, lower row) were visible in infected cells. Scale bar: 2 mm. One of three
experiments is shown.representative of 36 cells that were analyzed. Overall, a Pearson
coefficient of 0.6 was reached, and 42% of autophagosomes
contained 12% of M2 in influenza A virus-infected cells.
In order to further support this M2 localization to autophago-
somes, we performed cell fractionation and density gradient372 Cell Host & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevcentrifugation to enrich autophagosomes from influenza A
virus-infected cells. The autophagosome distribution in these
density fractions was then determined by characterizing the
enrichment of the Atg8 homologs LC3 (MAP1LC3B) and
Gate16 (GABARAPL2); of Rab7, involved in autophagosomeier Inc.
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Macroautophagy Inhibition by InfluenzaFigure 4. Influenza A Virus M2 Blocks Autophagosome Fusion with Lysosomes
(A) GFP-Atg8/LC3-transfected A549 human lung epithelial cells were transfected with expression plasmids encoding either FLAG-tagged M2 or NP of influenza
A/WSN/33 virus. Twenty-four hours after transfection, GFP-ATG8/LC3-positive autophagosome accumulation was analyzed by fluorescence microscopy. Influ-
enza M2-specific antibodies were used for M2 detection and an anti-FLAG antibody for NP detection. Scale bar: 80 mm. One of three experiments is shown.
(B) Left: western blot analysis of lipidated endogenous Atg8/LC3-II accumulation in A549 cells transfected with M2 or NP. Right: western blot analysis of M2 and
NP expression in transfected cells, using anti-FLAG-tag staining. One of three experiments is shown.
(C) Colocalization analysis of M2 (red fluorescence) and GFP-LC3 (green fluorescence) in infected A549 cells: serial optical sections (0.2 mm; 40 sections) were
acquired, and images were then deconvoluted using Huygens software. Pearson coefficients were calculated using the Imaris 6.3.0 software. White fluorescence
represents colocalization. Scale bar: 10 mm. One representative of 36 analyzed cells is shown.
(D) Mass spectrometric analysis of density gradient fractions (1–6) of influenza A virus-infected A549 cells content upon influenza infection in A549 cells. Cell
organelle marker protein distribution in these fractions was determined by mass spectrometric sequencing of protein fragments. Influenza A virus M2 distribution
follows the distribution of autophagosome marker protein (right panel) but not the distribution pattern of mitochondria and endoplasmic reticulum (ER) proteins.
One of four experiments is shown.fusion with lysosomes (Ja¨ger et al., 2004); and of the classical
macroautophagy substrates p62/SQSTM1 (Komatsu et al.,
2007), glyceraldehydephosphate dehydrogenase (GAPDH)
(Fengsrud et al., 2000), and lactate dehydrogenase A/B (LDHA/B)
(Stromhaug et al., 1998). The distribution of these proteins
was determined by peptide fragment analysis via mass spec-
trometry (Kristensen et al., 2008). This analysis revealed that influ-
enza A virus M2 enrichment in density gradient fractions of in-
fected A549 cells followed the profile of autophagosome
markers, but not mitochondrial and endoplasmic reticulum
proteins (Figure 4D). These findings suggest that M2 accumu-
lates in regular autophagosomes and prevents their fusion with
lysosomes.
M2 Is Necessary for Autophagosome Accumulation
during Influenza Virus Infection
In order to demonstrate that M2 is necessary for the block of
autophagosome degradation by influenza A virus infection, weCell Housed two strategies. In a first set of experiments, we used
M2-specific RNA interference, and in a second set of experi-
ments, we used an M2 knockout virus.
Silencing of M2 protein expression during influenza A virus
infection significantly decreased autophagosome accumulation
in infected cells (Figure 5A). Indeed, downregulation of M2 by
RNA interference reverted the phenotype of infected cells
from containing perinuclear autophagosome accumulations to
homogenous GFP-Atg8/LC3 distribution. This difference was
statistically significant (p < 0.001) (Figure 5B). Loss of M2 by
this treatment did, however, not prevent infection by influenza
A virus, because NP expression was similar in control siRNA or
M2-specific siRNA-treated cells (Figure 5A). This loss of function
by M2 silencing was also observed in western blot analysis.
Atg8/LC3-II upregulation during influenza A virus infection was
significantly decreased upon M2-specific RNA interference
(Figure 5C). To further confirm this finding, we constructed an
M2 knockout virus on the A/PR8/34 influenza strain backgroundst & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc. 373
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Macroautophagy Inhibition by InfluenzaFigure 5. Loss of Influenza A Virus M2 Expression during Infection Prevents Autophagosome Accumulation
(A) GFP-Atg8/LC3-transfected A549 cells were transfected with M2-specific siRNA or a control siRNA and analyzed by fluorescence microscopy 24 hr after infec-
tion. In order to monitor influenza A virus infection and M2 expression, costaining for NP and M2 was performed. Scale bar: 30 mm. One of three experiments is
shown.
(B) Summary of perinuclear autophagosome accumulation in influenza A virus-infected cells with and without M2-specific RNA silencing of three independent
experiments. In each experiment, at least 150 cells were analyzed per condition. Statistical analysis was performed by applying Pearson’s chi-square test.
(C) Western blot analysis of lipidated Atg8/LC3-II accumulation in influenza-infected A549 cells transfected with M2 siRNA or control siRNA. One of three exper-
iments is shown.
(D) GFP-Atg8/LC3-transfected A549 cells at 24 hr after infection with M2-deficient (M2 PR8) or wild-type influenza A virus (WT PR8). Infection was visualized by
staining for NP. Scale bar: 100 mm.
(E) Western blot analysis of Atg8/LC3-II, M2, and NP expression in influenza A virus-infected A549 cells using the two recombinant influenza A viruses (M2 PR8
and WT PR8) at mois of 1 and 10 and influenza A/X:31 virus as a control. One of five experiments is shown.374 Cell Host & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc.
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can perform only single-round replications in cell culture and
therefore allows the analysis of cell biological effects of M2
loss without confounding effects due to blocked secondary
infections. A549 cells infected with the M2-deficient virus did
not show any accumulation of autophagosomes, as depicted
by the GFP-Atg8/LC3 fluorescence analysis (Figure 5D). We
also could not detect any Atg8/LC3-II accumulation by western
blot analysis at 24 hr after infection with two different concentra-
tions of M2 knockout virus (moi = 1 and moi = 10) (Figure 5E),
while wild-type influenza A/PR8/34 virus produced with the
same reverse genetics approach was capable to arrest autopha-
gosome degradation. This difference was not due to a diminished
infectivity of the M2-deficient virus, as documented by NP
expression (immunofluorescence and western blot analysis
[Figures 5D and 5E]). These data suggest that M2 protein is suffi-
cient and necessary to inhibit fusion of autophagosomes with the
lysosomal compartment and thereby prevents degradation of
macroautophagy substrates during influenza A virus infection.
The Proton Channel Activity of M2 Is Not Involved
in Blocking Autophagosome Degradation
The major function of M2 is its activity as selective proton
channel during viral entry. Therefore, we hypothesized that M2
localization in the autophagosomal membranes could prevent
the acidification of these vesicles and thereby inhibit their effi-
cient fusion with lysosomes (Yamamoto et al., 1998). We first
used the antiviral drug amantadine hydrochloride (AMA), an
aminoadamantane known to inhibit the proton channel activity
of M2 (Hay et al., 1985). This inhibitor was unable to prevent
autophagosome accumulation in M2-transfected or influenza A
virus-infected cells (Figure 6A). In order to confirm that viral
proton channel activity alone was not sufficient for autophago-
some accumulation, we tested influenza B virus infection.
Influenza B virus’ proton channel BM2 facilitates influenza B
virus acidification during its cellular entry (Mould et al., 2003).
The homology between M2 of influenza A virus and the BM2
protein of influenza B virus is, however, restricted to the HXXXW
motif of the membrane-spanning residues, known to be critical
for the proton channel activity (Ma et al., 2008). Surprisingly,
influenza B infection did not result in autophagosome accumula-
tion (Figure 6B). Moreover, mutating the H37 of M2 to glycine
(M2H37G), which abolishes proton channel activity (Stouffer
et al., 2008), did not decrease lipidated Atg8/LC3-II accumula-
tion in M2-transfected cells (Figure 6C). These data suggest
that M2’s proton channel activity is not involved in blocking
autophagosome fusion with lysosomes.
We next investigated if the cytoplasmic domain of M2 was
involved in autophagosome accumulation. We constructed a
truncated form of M2, encoding for only the first 60 amino acids
(M21–60). M21–60 transfection was still able to cause accumulation
of lipidated Atg8/LC3-II (Figure 6C). We conclude from these data
that the C-terminal cytoplasmic domain of M2 is not involved in
autophagosome accumulation during influenza A virus infection.
Finally, in order to get a first insight into how M2 blocks auto-
phagosome fusion with lysosomes, we analyzed if it could
interact with the molecular machinery of macroautophagy. We
performed immunoprecipitations of M2 to identify associated
Atg proteins. We identified Atg6/Beclin-1 in M2 immunoprecipi-Cell Hotates from influenza A virus-infected A549 cells. Similarly, M2
coimmunoprecipitated with Atg6/Beclin-1 from infected cells
(Figure 6D). Furthermore, the N-terminal 60 amino acids of M2
were able to interact with Beclin-1 (Figure 6E). M21–60 and full-
length M2 were coimmunoprecipitated with Atg6/Beclin-1 to a
similar degree. These results give a first indication that M21–60
might interfere with the Atg6/Beclin-1- and UVRAG-containing
PI3K complex, which has been recently described to facilitate
autophagosome fusion with lysosomes (Matsunaga et al.,
2009; Zhong et al., 2009; Itakura et al., 2008).
Thus, M2 of influenza A virus blocks autolysosome formation
with its N-terminal 60 amino acids, independently of its proton
channel function, possibly through interfering with the Atg6/
Beclin-1- and UVRAG-containing PI3K complex.
Macroautophagy-Deficient Cells Are More Susceptible
to Apoptosis upon Influenza Infection
In order to understand the functional relevance of macroautoph-
agy inhibition upon influenza A virus infection, we used wild-type
and macroautophagy-deficient MEFs. Loss of macroautophagy
was achieved by knockout of the essential macroautophagy
gene atg5 (Kuma et al., 2004). Although wild-type and atg5/
MEFs were similarly susceptible to apoptosis as measured by
annexin V and 7-AAD staining in flow cytometry, influenza A virus
infection induced significantly more cell death in macroautoph-
agy-deficient MEFs across a broad range of different infectious
doses (Figure 7A). Moreover, this susceptibility to apoptosis of
atg5/ MEFs was observed at several time points (6, 12, and
24 hr) after influenza A virus infection (Figure 7B). Across the
different infectious doses and infection time points, influenza
A-infected atg5/ MEFs consistently contained up to 4-fold
more apoptotic and secondary necrotic cells than infected
wild-type MEFs (paired t test, p = 0.005). The difference in
apoptosis was most pronounced 12 hr after infection and at an
infectious viral dose of 120 HAU/106 cells. Thus, loss of autopha-
gosome formation compromises the survival of influenza-
infected cells. Furthermore, loss of the M2 block of autophago-
some degradation resulted in increased survival of M2 knockout
influenza A virus-infected cells (Figures 7C and 7D). The cell
death was analyzed 24 hr after the infection of A549 lung epithe-
lial cells with M2-deficient and wild-type virus. Therefore, allow-
ing completion of macroautophagy by lifting the M2-mediated
block of autophagosome fusion with lysosomes enhances
survival of influenza-infected cells. These data suggest that mac-
roautophagy serves as a survival pathway in influenza-infected
cells, since its deficiency leads to enhanced apoptosis, and
restoring completion of macroautophagy leads to decreased
apoptosis.
Macroautophagy Deficiency Enhances Viral Protein
Release but Not Viral Replication
In order to investigate if this enhanced cell death of macro-
autophagy-deficient cells after influenza A virus infection affects
virus release, we performed HA-specific ELISA assays with the
supernatants of infected atg5+/+ and atg5/MEFs. We detected
increased viral protein release from infected macroautophagy-
deficient cells (Figure S2A). Four times more HA was released
from infected Atg5-deficient MEFs than from infected wild-type
cells. Furthermore, the viral protein content was higher inst & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc. 375
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deficient cells (Figure S2B). Similarly, more viral RNA was
retained in Atg5-positive than -negative cells after influenza A
virus infection (7.94-fold ± 2.68; p = 0.0005). These values
were normalized to GAPDH (Figure S2C, left); these data suggest
that macroautophagy-competent cells retain more viral protein
and RNA within influenza A virus-infected cells.
However, we did not detect higher viral titers in the superna-
tants of macroautophagy-competent cells after influenza A virus
infection (Figure S2D). In these experiments, influenza A virus
titers were determined by MDCK plaque assay. No significant
differences were detected in virus infectivity from supernatants
Figure 6. The Proton Channel Function of M2 Is
Not Involved in Autophagosome Accumulation
(A) GFP-Atg8/LC3-transfected A549 human lung
epithelial cells were infected with influenza A virus
and incubated 1 hr later with and without amantadine
at a concentration of 50 mM. Cells were stained with
M2 antibody and analyzed for GFP-Atg8/LC3-positive
autophagosome accumulation by fluorescence
microscopy. Nuclear DNA was stained with DAPI.
Scale bar: 100 mm. Representative images of one of
three experiments are shown.
(B) GFP-Atg8/LC3-transfected A549 cells were
infected with influenza A or B and analyzed by fluores-
cence microscopy for autophagosome accumulation.
DAPI was used to stain nuclear DNA. Scale bar:
100 mm. One of three experiments is shown.
(C) A549 cells were transiently transfected with M2
wild-type and M2 mutants (M2 H37G and M2
stop60) encoding plasmids. Twenty-four hours after
transfection, Atg8/LC3-II accumulation was analyzed
by western blot analysis. One of three experiments is
shown.
(D) A549 cells were infected with X:31 virus; 24 hr later,
cell lysates from infected and noninfected cells were
immunoprecipitated using Atg6/Beclin-1-specific
(left) or M2-specific antibodies (right). Western blotting
was performed for Atg6/Beclin-1 and influenza A virus
M2 detection. One of three experiments is shown.
(E) A549 cells were transfected with full-length (WT)
or the 60 N-terminal amino acids of M2 (stop60).
Transfected or nontransfected cells were immunopre-
cipitated using Atg6/Beclin-1- or M2-specific anti-
bodies (Atg6/Beclin-1 IP, left panel; M2 IP, right panel).
Western blotting was performed for Atg6/Beclin-1
(top) and M2 (bottom) detection. * indicates immuno-
globulin light chain of the antibodies used for immuno-
precipitation. One of three experiments is shown.
collected from atg5+/+ and atg5/ MEFs.
Overall, these data suggest that macroau-
tophagy-competent cells accumulate more
viral RNA and viral proteins than macroau-
tophagy-deficient cells, but this does not
result in higher infectious virus release.
DISCUSSION
Our study characterizes inhibition of macro-
autophagy by influenza A virus at the check-
point of autophagosome fusion with lyso-
somes. We identify M2 as the viral protein mediating this block
in autophagosome degradation and document that macroau-
tophagy downmodulation leads to enhanced virus-induced cell
death of infected cells and elevated viral antigen release.
However, influenza A virus is not the first pathogen that has
been described to interfere with macroautophagy. Indeed, as
early as 1965, Sam Dales and colleagues documented that
poliovirus infection leads to the accumulation of double-
membrane coated vesicles (Dales et al., 1965). Later, it was
reported that the formation of these membrane compartments
depends on some components of the macroautophagic machin-
ery and is required for efficient viral replication (Jackson et al.,376 Cell Host & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc.
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Macroautophagy Inhibition by InfluenzaFigure 7. Macroautophagy Inhibition Enhances Cell Death after Influenza A Virus Infection
(A) Wild-type (atg5+/+) and macroautophagy-deficient (atg5/) MEFs were infected with the indicated doses of influenza A virus (HA units [HAU] per 106 cells) and
analyzed 24 hr later by flow cytometry. Staining for M2, 7-AAD, and annexin V was performed. Cells were gated on M2-positive cells, and apoptosis (annexin
V-positive) and secondary necrosis (annexin V- and 7-AAD-positive) cells were quantified. The percentage of double-positive cells (annexin V- and 7-AAD-posi-
tive) is significantly higher in atg5/ cells (paired t test, p = 0.005). One of five experiments is shown.
(B) Cell death induction was analyzed as in (A), but with one constant influenza A virus infection dose (1200 HAU/106 cells) at the indicated time points. One of
three experiments is shown.
(C) A549 cells were infected with the M2-deficient or the wild-type recombinant virus at an moi of 1, and cell death was analyzed at 24 hr after infection. Cells were
gated on infected cells (anti-H1N1 FITC), and apoptosis (annexin V-positive) and secondary necrosis (annexin V- and 7-AAD-positive) cells were quantified.
(D) Composite data on five independent experiments comparing apoptosis (Annexin V+) and secondary necrosis (7-AAD+ Annexin V+) after M2-deficient
(M2 PR8) and wild-type (WT PR8) influenza A virus infection of A549 cells. Error bars indicate SD.2005). Similarly, hepatitis C virus (HCV) infection leads to the
accumulation of Atg8/LC3-positive vesicles, while not affecting
the turnover of classical macroautophagy substrates (Sir et al.,
2008). The accumulating vesicles seem to be required for HCV
replication. However, even though autophagic replication com-
partments of pathogens seem to be stabilized and not degraded
within minutes as regular autophagosomes are, the molecular
mechanism (at the level of individual proteins blocking autopha-Cell Hosgosome fusion with lysosomes) remains unclear (Mu¨nz, 2009). In
contrast to this second checkpoint of macroautophagic flux,
inhibition of autophagosome formation as a first checkpoint
during macroautophagy has been reported and characterized
in more detail for several pathogens. Herpesviruses have proven
a rich source of inhibitors of macroautophagy. Members of the
g-herpesviridae, namely Kaposi’s sarcoma-associated herpes-
virus (KSHV) and mouse herpesvirus 68 (MHV-68), have beent & Microbe 6, 367–380, October 22, 2009 ª2009 Elsevier Inc. 377
Cell Host & Microbe
Macroautophagy Inhibition by Influenzademonstrated to encode Bcl-2 homologs that inhibit autophago-
some initiation via their binding to Atg6/Beclin-1, a component of
the class III PI3K complexes that are required for macroautoph-
agy (Ku et al., 2008; Pattingre et al., 2005; Sinha et al., 2008).
Similarly, the a-herpesvirus HSV-1 encodes ICP34.5, which
also contains an Atg6/Beclin-1-interacting domain, which
inhibits macroautophagy (Orvedahl et al., 2007). Interestingly,
HSV-1 with an ICP34.5 protein deficient in this domain is
attenuated in its neurovirulence in mice. Consistent with this
role of macroautophagy for resistance to HSV infection in vivo
is that Sindbis virus, transgenic for Atg6/Beclin-1 and thereby
enhancing macroautophagy upon infection, is attenuated in
mice (Liang et al., 1998). While our study was being prepared
for publication, influenza A virus was also reported to affect
autophagosome formation to enhance its replication (Zhou
et al., 2009). While we cannot exclude that influenza A virus might
upregulate macroautophagy via innate immune recognition by
PAMP receptors in certain cell types (Delgado et al., 2008), we
could only identify one viral protein, namely M2, that blocks
autophagosome degradation, and this was also the main mech-
anism of autophagosome accumulation in human lung epithelial
cells after infection with a variety of influenza A virus strains.
Interestingly, M2 might also target Atg6/Beclin-1 for this func-
tion, possibly interfering with the Atg6/Beclin-1- and UVRAG-
containing PI3K complex, which was recently characterized to
support autophagosome fusion with lysosomes (Matsunaga
et al., 2009; Zhong et al., 2009; Itakura et al., 2008). Therefore,
pathogens target macroautophagy at two checkpoints, during
autophagosome formation and during autophagosome fusion
with lysosomes, and we have characterized a specific viral
protein that blocks autophagosome degradation.
Apart from mediating immunity, as has been demonstrated for
other pathogens, we demonstrate that macroautophagy can
also influence the death of the pathogen’s host cell. In addition
to regulation of the prosurvival pathway of macroautophagy by
influenza A virus, several viruses influence apoptosis of infected
cells (Galluzzi et al., 2008). Although one would intuitively
assume that it is in the virus’ interest to prolong the life of infected
cells in order to maximize viral replication, pro- and antiapoptotic
mechanisms are employed by viruses to nearly the same extent
(Galluzzi et al., 2008). While more antiapoptotic proteins have
been identified in DNA viruses, like Bcl-2 homologs of herpesvi-
ruses, RNA viruses encode more proapoptotic factors. Among
the most prominent pathogens that trigger apoptosis are the
RNA viruses HIV and influenza. Influenza A virus encodes the
proapoptotic protein PB1-F2 (Chen et al., 2001). It inserts into
the mitochondrial membrane (Gibbs et al., 2003), causing pores
in lipid bilayers (Chanturiya et al., 2004), and also directly inter-
acts with ANT and VDAC (Zamarin et al., 2005). Although it is
not entirely clear if PB1-F2 causes mitochondrial membrane per-
meabilization by regulation of ANT and VDAC or its direct pore-
forming capacity, this proapoptotic function of influenza A virus
is required for pathogenesis in mice (Zamarin et al., 2006).
Furthermore, PB1-F2 is in part responsible for the increased
pathogenesis of the H5N1 ‘‘bird flu’’ and the 1918 ‘‘Spanish
flu’’ (McAuley et al., 2007; Conenello et al., 2007). Indeed, only
a single amino acid mutation was responsible for the increased
pathogenicity of PB1-F2 of these highly virulent influenza A
strains (Conenello et al., 2007). These studies suggest that378 Cell Host & Microbe 6, 367–380, October 22, 2009 ª2009 ElsevRNA viruses like influenza induce apoptosis and thereby regulate
the cell death of their host cells.
Even though proapoptotic proteins have now been identified
from many pathogens, and we show in this study that influenza
inhibits the prosurvival pathway of macroautophagy, the func-
tional benefit of enhanced host cell death during infection still
remains largely unclear. We propose three possible advantages
of macroautophagy inhibition for influenza A virus. First, deple-
tion of immune system cells and lung epithelial cells by apoptosis
could facilitate influenza A virus infection by limiting virus-
specific immune responses and compromising the lung barrier
function. Within the cells of the immune system, macrophages
have been found to be especially sensitive to influenza A virus-
induced cell death (Bender et al., 1998), and highly pathogenic
influenza virus strains were superior in lung lesion induction
and dendritic cell depletion early during influenza A virus infec-
tion of macaques (Baskin et al., 2009). Second, influenza A
virus-induced apoptosis has been demonstrated to limit proin-
flammatory cytokine production (Brydon et al., 2003). In good
agreement, we find that viral RNA, which can be recognized as
a PAMP to trigger inflammatory cytokine responses, is more
readily retained in macroautophagy-competent cells after influ-
enza infection (Figure S2). Therefore, induction of apoptotic
cell death by influenza A virus in macroautophagy-competent
cells could limit the immunogenicity of viral infection. Along these
lines, it has been suggested that apoptotic bodies are less immu-
nogenic than necrotic cell debris (Sauter et al., 2000). Moreover,
ATP production by macroautophagy seems required to expose
phosphatidylserine on apoptotic bodies for efficient engulfment
by phagocytes and for the production of lysophosphatidylcho-
line to attract macrophages (Qu et al., 2007). Third, we demon-
strate that macroautophagy-competent cells retain more virus-
derived antigens after influenza infection. The enhanced viral
antigen release by macroautophagy-deficient cells (Figure S2)
could increase the antigenicity of influenza virus infection, which
might be avoided by trapping of viral antigens in autophago-
somes and preventing their degradation for direct presentation
on MHC molecules via M2. Therefore, influenza A virus-induced
cell death by apoptosis induction and macroautophagy inhibition
could eliminate immune and barrier cells that limit viral spreading
and render the death of infected cells as little immunogenic as
possible. Since PB1-F2 is mainly expressed during later stages
of the infection cycle (Chen et al., 2001), and we observed auto-
phagosome accumulation also only at later time points after
infection (R10 hr), the virus might induce host cell death with
low immunogenicity in an ordered fashion after efficient initial
replication.
In summary, we have identified the influenza A virus protein M2
as an inhibitor of autophagosome fusion with lysosomes, and
this inhibition seems to target, with macroautophagy, a pathway
that prevents apoptosis of infected cells.
EXPERIMENTAL PROCEDURES
Cell Lines
The following epithelial cell lines were used: the human keratinocyte cell line
HaCat (a gift of Rajiv Khanna; Brisbane, Australia), the human breast carci-
noma cell line MDAMC (a gift from Irene Joab; Paris), the human lung epithe-
lium cell line A549 (a gift from Thomas Moran; New York), the mouse lung
epithelium cell line MLE-12 (a gift from Arnoud Didierlaurent; London), theier Inc.
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Macroautophagy Inhibition by Influenzacanine kidney epithelium cell line MDCK and the human cervix carcinoma cell
line HeLa (both ATCC; Manassas, VA), and the wild-type and Atg5-deficient
MEFs (a gift from Noboru Mizushima; Tokyo). All epithelial cell lines were
routinely cultured in DMEM with 10% FCS (Sigma; St. Louis, MO), 2 mM gluta-
mine, 110 mg/ml sodium pyruvate, and 2 mg/ml gentamicin, except MLE-12,
which was cultured in a 50:50 mix of DMEM:Ham’s F12 supplemented with
2% FCS, 5 mg/ml insulin, 10 mg/ml transferrin, 30 mM sodium selenite,
10 nM hydrocortisone, 10 nM b-estradiol, 2 mM glutamine, and 2 mg/ml genta-
micin. Epithelial cell monolayers were detached by one wash in PBS/0.5 mM
EDTA followed by incubation in 0.05% trypsin/0.53 mM EDTA (GIBCO; North
Andover, MA). Cell lines stably expressing GFP-LC3 were generated by lenti-
viral infection with mois of 10–40.
Antibodies
Primary Antibodies
Anti-LC3 antiserum was generated as previously described (Schmid et al.,
2007) by immunizing two rabbits with the N-terminal peptide LC31–15
(MPSEKTFKQRRTFEQR) conjugated to KLH carrier protein (Cocalico Biolog-
icals; Reamstown, PA). The rat anti-FLAG antibody was a gift from Cheolho
Cheong (New York).
The following antibodies specific for influenza proteins were used: two influ-
enza M2-specific monoclonal antibodies, M2-E10 (a gift from Tom Moran,
New York) and M2-Clone 14C2 (Affinity Bioreagents; Rockford, IL); an influ-
enza MP1-specific rabbit antiserum (a gift from Ari Helenius, Zu¨rich); an influ-
enza NP-specific rabbit antiserum (a gift from Peter Palese, New York); and an
influenza NS1-specific monoclonal antibody (a gift from Peter Palese). For
human p62/SQSTM1, a specific guinea pig antiserum (C terminus-specific,
American Research Products; Belmont, MA) and monoclonal antibodies
against LAMP1 (clone H4A3, Southern Biotech; Birmingham, AL), against actin
(clone AC-40, Sigma), and against polyubiquitinated proteins (clone FK-1,
Cosmo Bio Co., Ltd.; Carlsbad, CA) were used. For Atg6/Beclin-1 detection,
we used a goat anti-Atg6/Beclin-1 (Santa Cruz Biotechnology; Santa Cruz,
CA) for immunoprecipitation and a rabbit polyclonal antiserum (Novus Biolog-
icals; Littleton, CO) for western blotting.
Secondary Antibodies
For immunofluorescence microscopy, we used Rhodamine Red-X (RRX)-
conjugated or Cy-3-conjugated donkey anti-mouse from Jackson Laboratory
(West Grove, PA), Alexa Fluor 568-conjugated goat anti-rat, Alexa Fluor 555-
conjugated donkey anti-rabbit, Alexa Fluor 647-conjugated rat anti-mouse,
and Alexa Fluor 647-conjugated goat anti-mouse (all from Invitrogen).
Influenza A Virus Infection
For most experiments, influenza A virus strain X31, A/Aichi/68 (H3N2) (purified
virus, purchased from Charles River Laboratories; Wilmington, MA) was used.
Where indicated, influenza B/Lee/40 (from Charles River Laboratories), influ-
enza A/PR8/34, and A/PR8/34DNS1 (H1N1) (Garcı´a-Sastre et al., 1998) or
A/WSN/33 and A/WSN/33DPB1F2 (H1N1) (Zamarin et al., 2005) were used.
Before infection, cells were washed three times in RPMI-1640 to remove
FCS and then incubated with influenza virus in a small volume of RPMI-1640
for 1 hr at 37C (moi = 0.1–2). After 1 hr, cells were washed once in PBS and
then incubated in culture medium (DMEM + 10% FCS + glutamine + genta-
micin) for the indicated amount of time, usually 24 hr. For heat inactivation,
virus was incubated in a 56C water bath for 30 min and then added to cells
as described above.
See Supplemental Experimental Procedures for details on flow cytometry;
inhibitors, synthetic peptides, and cytokines; expression plasmids and lenti-
viral constructs; siRNA-mediated gene silencing; M2-deficient recombinant
influenza A/PR8/34 virus generation; immunocytochemistry and confocal
microscopy; live cell imaging; electron microscopy; lysate preparation, SDS-
PAGE, and immunoblotting; immunoprecipitation; HA ELISA assay; quantifi-
cation of viral RNA; influenza virus titration; and statistics.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, two figures, and one movie and can be found online at
http://www.cell.com/cell-host-microbe/supplemental/S1931-3128(09)00314-X.Cell HosACKNOWLEDGMENTS
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